| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0d9a06f4c98fe19ed3db1ae100d48e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
| filingDate |
2013-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bd929386e6f7747238b58ea7126c7c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6126612cb6aaba8b0a71d9bf837f275 |
| publicationDate |
2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140088422-A |
| titleOfInvention |
Memantine as a therapeutic treatment of fetal valproate syndrome |
| abstract |
The present invention relates to memantine, a substance for treating social deficit symptoms, and more particularly, to a treatment for psychiatric diseases, wherein the NMDA receptor antagonist memantine effectively treats the symptoms of sociability deficiency and convulsive sensitivity increase in congenital valproic acid exposure syndrome Can be used. |
| priorityDate |
2013-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |